Hongwen Deng

Has grant

Founding Director

Tulane University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

ROBUST AND POWERFUL TEST OF CANDIDATE GENES TO BONE MASS

Open Date:

Close Date:

Grant: Close

PROTEOMICS STUDY OF PERIPHERAL BLOOD MONOCYTES ON OSTEROPORSIS

Open Date:

Close Date:

Grant: Close

GENETICS OF OSTEOPOROTIC FRACTURES IN CHINESE

Open Date:

Close Date:

Grant: Close

GENOMIC SEARCH FOR BONE MASS QTLS

Open Date:

Close Date:

Grant: Close

EPIGENOMEWIDE DNA METHYLATION STUDY FOR OSTEOPOROSIS RISK

Open Date:

Close Date:

Articles (12)

Year:

2026

Year:

2026

Motivation Understanding spatial organization, intercellular interactions, and regulatory networks within the spatial context of tissues is crucial for uncovering complex biological processes and disease mechanisms. Spatial transcriptomics technologies have revolutionized this field by enabling the spatially resolved profiling of gene expression. 10× Visium has emerged as the predominant spatial technology, but its low resolution and the complexity of integrating multimodal datasets present significant analytical challenges, particularly for researchers with limited computational and statistical expertise. Current spatial transcriptomics analysis platforms generally fall short of effectively integrating multimodal data and maximizing the utility of spatial information—such as uncovering complex cellular spatial dependencies, multimodal gradient patterns, and spatial coexpression of ligand–receptor pairs and regulatory networks related to disease or biological states—thereby limiting their ability to provide comprehensive end-to-end analytical workflows when analyzing 10× Visium data. Results To address these limitations, we developed transFusion, a novel, advanced web-based platform specializing in the most comprehensive and effective integration analysis of scRNA-seq and 10× Visium spatial transcriptomics data. transFusion offers 12 key functions, from basic visualization to advanced analyses, including intercellular dependency analysis, ligand–receptor coexpression identification and visualization, and spatial multimodal gradient variation patterns. Two case studies were used to demonstrate transFusion’s capabilities in exploring tissue architecture, intercellular communication, dependency networks, and multimodal gradient variation patterns with minimal computational skills and statistical expertise. transFusion provides a flexible and powerful framework for multimodal data integration analysis. Availability and implementation transFusion is freely available at https://github.com/WQLin8/transFusion.

Year:

2026

While both Primary Age-Related Tauopathy (PART) and Alzheimer’s Disease (AD) involve the accumulation of hyperphosphorylated tau (pTau)-positive neurofibrillary tangles (NFTs) in the hippocampus, PART is distinguished by the absence of β-amyloid (Aβ) deposition and is generally associated with milder cognitive impairment than AD. To delineate cellular and molecular mechanisms that are common or uniquely linked to disease progression in PART and AD, we constructed a transcriptome-wide, high-resolution atlas of the human hippocampus using samples from six individuals spanning the aged control (AC), PART, and AD groups. Our results supported that PART represent a precursor stage of AD, as evidenced by the altered transcriptional profiles of excitatory neurons (Exc) in the PART group, which exhibited a markedly increased capacity to promote Aβ production compared to both AC and AD groups. While the microglia (Mic) were reactivated in the PART group, this response was reduced in AD samples despite the presence of Aβ deposition, and appeared to further induce NFTs formation as a loop consequently driving the progression from PART to AD. Furthermore, subregion interactions in the signalling pathways related to neuronal survival and the maintenance of blood-brain-barrier (BBB) integrity were decreasing in the PART and disrupted in the AD groups, compared to the AC group. Additionally, we found a P53 signalling-related gene, TP53INP2 , was uniquely upregulated in astrocytes near large vessels in AD. This suggests a potential mechanism of vessel-induced neuronal apoptosis in AD, a feature absent in AC and PART. In summary, our study offers new insights into the relationship between PART and AD, along with the molecular mechanisms driving the transition from PART to AD. Furthermore, we identified key molecular pathways associated with BBB disruption and vascular-associated neuronal degradation in AD which were absent in PART. These findings deepen our understanding of AD pathogenesis and may inform the development of targeted therapeutic strategies.

Year:

2025

Bone and skeletal muscle are essential components of the musculoskeletal system, enabling movement, load-bearing, and systemic regulation. These tissues communicate through dynamic bone-muscle crosstalk mediated by cytokines, growth factors, and extracellular matrix (ECM) proteins. The spatial organization of these mediators is critical to maintaining tissue integrity, and disruptions contribute to diseases such as osteoporosis, sarcopenia, and metabolic syndrome. Despite the importance of spatial context, studies using spatial transcriptomics (ST) to investigate bone-muscle interactions remain limited. Here, we applied 10X Genomics Visium ST profiling and advanced computational tools to characterize cell-cell communication networks and ligand-receptor (L-R) interactions in mouse femur and adjacent skeletal muscle. We identified eight major cell types: erythroid cells, endothelial cells, skeletal muscle cells, osteoblasts, myeloid cells, monocytes/macrophages, mesenchymal stem cells, and adipocytes, each exhibiting distinct spatial gene expression profiles. Signaling pathway analysis revealed 13 key pathways mediating intra- and inter-tissue communication, including COLLAGEN, THBS, VEGF, FN1, and TENASCIN. Notable L-R pairs involved in bone, muscle, and bone-muscle crosstalk include Col1a2-Sdc4 (osteoblast–ECM interactions), Tnxb-Sdc4 (muscle-to-endothelial signaling), Vegfa-Vegfr1 and Vegfa-Vegfr2 (muscle-to-endothelial/myeloid signaling), and Comp-Sdc4 (monocyte/macrophage-to-osteoblast signaling). This study presents the first spatially resolved map of cell-cell communication across bone and skeletal muscle, providing novel insights into their molecular crosstalk. These findings offer a critical foundation for future therapeutic strategies targeting musculoskeletal disorders.

Year:

2025

Osteosarcoma is the most common primary malignant bone tumor in childhood. Patients who present with metastatic disease at diagnosis or relapse have a very poor prognosis, and this has not changed over the past four decades. The Wnt signaling pathway plays a role in regulating osteogenesis and is implicated in osteosarcoma pathogenesis. DKK-1 inhibits the canonical Wnt signaling pathway, causing inhibition of osteoblast differentiation and disordered bone repair. Our lab previously demonstrated that an mAb against DKK-1 prevented metastatic disease in a mouse model. This study expands upon those findings by demonstrating similar results with a small-molecule inhibitor of DKK-1, WAY262611, both in vitro and in vivo . WAY262611 was evaluated in vitro on osteosarcoma cell lines, including proliferation, caspase activation, cell-cycle analysis, and signaling pathway activation. We utilized our orthotopic implantation/amputation model of osteosarcoma metastasis in vivo to determine the impact of WAY262611 on primary tumor progression and metastatic outgrowth of disseminated tumor cells. Differentiation status was determined using single-cell RNA sequencing. We show here that WAY262611 activates canonical Wnt signaling, enhances nuclear localization and transcriptional activity of β-catenin, and slows proliferation of osteosarcoma cell lines. We also show that WAY262611 induces osteoblastic differentiation of a patient-derived xenograft of osteosarcoma in vivo , as well as inhibiting metastasis. This work credentials DKK-1 as a therapeutic target in osteosarcoma, allowing for manipulation of the Wnt signaling pathway and providing preclinical justification for the development of new biologics for the prevention of osteosarcoma metastasis.

Year:

2025

Supplementary Figure S1 shows results from toxicity evaluation of WAY262611, the effect of WAY262611 on the growth of the primary tumor and on mouse survival, as well as examples of metastatic lesions.

Year:

2025

Background Sarcopenia presents a pressing public health concern due to its association with age‐related muscle mass decline, strength loss and reduced physical performance, particularly in the growing older population. Given the absence of approved pharmacological therapies for sarcopenia, the need to discover effective pharmacological interventions has become critical. Methods To address this challenge and discover new therapies, we developed a novel M ulti‐ T ask A ttention‐aware method for M ulti− O mics data (MTA−MO) to extract complex biological insights from various biomedical data sources, including transcriptome, methylome and genome data to identify drug targets and discover new therapies. Additionally, MTA‐MO integrates human protein–protein interaction (PPI) networks and drug‐target networks to improve target identification. The novel method is applied to a multi‐omics dataset that included 1055 participants aged 20–50 (mean (± SD) age 36.88 (± 8.64)), comprising 37.82% African‐American and 62.18% Caucasian/White individuals. Physical activity levels were self‐reported and categorized into three groups: ≥ 3 times/week, < 3 times/week and no regular exercise. Mean (± SD) measures for grip strength, appendicular lean mass (ALM), exercise frequency and smoking status (no/yes, n (%)) were 38.72 (± 8.93) kg, 28.65 (± 4.63) kg, 4.31 (± 1.79) and 30.81%/69.19%, respectively. Significant differences ( p < 0.05) were found between groups in age, ALM, smoking, and consumption of milk, alcohol, beer and wine. Results Using the MTA‐MO method, we identified 639 gene targets, and by analysing PPIs and querying public databases, we narrowed this list down to seven potential hub genes associated with sarcopenia ( ESR1 , ATM , CDC42 , EP300 , PIK3CA , EGF and PTK2B) . These findings were further validated through diverse levels of pathobiological evidence associated with sarcopenia. Gene Ontology and KEGG pathways analysis highlighted five key functions and signalling pathways relevant to skeletal muscle. The interaction network analysis identified three transcriptional factors ( GATA2 , JUN and FOXC1 ) as the key transcriptional regulators of the seven potential genes. In silico analysis of 1940 drug candidates identified canagliflozin as a promising candidate for repurposing in sarcopenia, demonstrating the strongest binding affinity to the PTK2B protein (inhibition constant 6.97 μM). This binding is stabilized by hydrophobic bonds, Van der Waals forces, pi‐alkyl interactions and pi‐anion interactions around PTK2B's active residues, suggesting its potential as a therapeutic option. Conclusions Our novel approach effectively integrates multi‐omics data to identify potential treatments for sarcopenia. The findings suggest that canagliflozin could be a promising therapeutic candidate for sarcopenia.

Year:

2025

Bone is a multifaceted tissue requiring orchestrated interplays of diverse cells within specialized microenvironments. Although significant progress has been made in understanding cellular and molecular mechanisms of component cells of bone, revealing their spatial organization and interactions in native bone tissue microenvironment is crucial for advancing precision medicine, as they govern fundamental signaling pathways and functional dependencies among various bone cells. In this study, we present the first integrative high-resolution map of human bone and bone marrow, using spatial and single-cell transcriptomics profiling from femoral tissue. This multi-modal approach discovered a novel bone formation-specialized niche enriched with osteoblastic lineage cells and fibroblasts and unveiled critical cell–cell communications and co-localization patterns between osteoblastic lineage cells and other cells. Furthermore, we discovered a novel spatial gradient of cellular composition, gene expression and signaling pathway activities radiating from the trabecular bone. This comprehensive atlas delineates the intricate bone cellular architecture and illuminates key molecular processes and dependencies among cells that coordinate bone metabolism. In sum, our study provides an essential reference for the field of bone biology and lays the foundation for advanced mechanistic studies and precision medicine approaches in bone-related disorders.

Year:

2025

Current treatments for Alzheimer’s disease (AD) focus on slowing memory and cognitive decline, but none offer curative outcomes. This study aims to explore and curate the common properties of active, drug-like molecules that modulate glycogen synthase kinase 3β (GSK-3β), a well-documented kinase with increased activity in tau hyperphosphorylation and neurofibrillary tangles—hallmarks of AD pathology. Leveraging quantitative structure–activity relationship (QSAR) data from the PubChem and ChEMBL databases, we employed seven machine learning models: logistic regression (LogR), k-nearest neighbors (KNN), random forest (RF), support vector machine (SVM), extreme gradient boosting (XGB), neural networks (NNs), and ensemble majority voting. Our goal was to correctly predict active and inactive compounds that inhibit GSK-3β activity and identify their key properties. Among the six individual models, the NN demonstrated the highest performance with a 79% AUC-ROC on unbalanced external validation data, while the SVM model was superior in accurately classifying the compounds. The SVM and RF models surpassed NN in terms of Kappa values, and the ensemble majority voting model demonstrated slightly better accuracy to the NN on the external validation data. Feature importance analysis revealed that hydrogen bonds, phenol groups, and specific electronic characteristics are important features of molecular descriptors that positively correlate with active GSK-3β inhibition. Conversely, structural features like imidazole rings, sulfides, and methoxy groups showed a negative correlation. Our study highlights the significance of structural, electronic, and physicochemical descriptors in screening active candidates against GSK-3β. These predictive features could prove useful in therapeutic strategies to understand the important properties of GSK-3β candidate inhibitors that may potentially benefit non-amyloid-based AD treatments targeting neurofibrillary tangles.

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Russell Swerdlow

University of Kansas Medical Center

UNITED STATES
View details

David Loeb

Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Mohammad Haeri

Assistant Professor

University of Kansas Medical Center

UNITED STATES
View details

Yuqi Tan

Stanford University

UNITED STATES
View details

Chao Xu

Associate Professor

University of Oklahoma Health Sciences Center

UNITED STATES
View details

Patrick Cahan

johns hopkins university school of medicine 1 department of biomedical engineering

UNITED STATES
View details

Hui Shen

Associate Professor

Tulane University

UNITED STATES
View details